Lazard Asset Management LLC Gossamer Bio, Inc. Transaction History
Lazard Asset Management LLC
- $58.2 Billion
- Q1 2025
A detailed history of Lazard Asset Management LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 43,761 shares of GOSS stock, worth $50,762. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,761
Previous 107,470
59.28%
Holding current value
$50,762
Previous $96,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GOSS
# of Institutions
127Shares Held
162MCall Options Held
2.11MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$21.3 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$21 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$11.7 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$9.34 Million7.27% of portfolio
-
Acadian Asset Management LLC Boston, MA6.36MShares$7.38 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $109M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...